Inflammatory pathways underlying atrial fibrillation
Authors:
- Anna KlinkeAKAnna Klinke
- Stephan BaldusSBStephan Baldus
- 1 October 2011
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 17 (10) , 556-563
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- The Interferon-γ-induced GTPase, mGBP-2, Inhibits Tumor Necrosis Factor α (TNF-α) Induction of Matrix Metalloproteinase-9 (MMP-9) by Inhibiting NF-κB and Rac ProteinJournal of Biological Chemistry, 2011
- Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidasesKidney International, 2011
- Assessment of Conventional Cardiovascular Risk Factors and Multiple Biomarkers for the Prediction of Incident Heart Failure and Atrial FibrillationJACC, 2010
- Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout miceFree Radical Biology and Medicine, 2010
- Redox-mediated reciprocal regulation of SERCA and Na+–Ca2+ exchanger contributes to sarcoplasmic reticulum Ca2+ depletion in cardiac myocytesFree Radical Biology and Medicine, 2010
- Myeloperoxidase acts as a profibrotic mediator of atrial fibrillationNature Medicine, 2010
- Intracardiac and extracardiac markers of inflammation during atrial fibrillationHeart Rhythm, 2010
- NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injuryNature Medicine, 2009
- Information Learned from Animal Models of Atrial FibrillationCardiology Clinics, 2009
- Atrial fibrosis and the mechanisms of atrial fibrillationHeart Rhythm, 2007